Email Newsletters

Marlborough

Office vacancy rates up, occupancy shrinks across much of MetroWest

Vacancy rates have risen and occupancy has shrunk for office space in MetroWest, according to a third-quarter report by Perry Brokerage Associates of Boston.

Wells Fargo analyst: Boston Scientific a potential target for Johnson & Johnson

New Jersey medical behemoth Johnson & Johnson could be eyeing Marlborough medical device giant Boston Scientific, according to a recent analyst report.

Boston Scientific gets FDA approval for blood device

Marlborough medical device giant Boston Scientific has been approved by U.S. regulators to market a device that helps deliver a sustained release of a drug to treat peripheral artery disease.

Mass. health insurers ask HPC for Question 1 analysis

Health insurers on Wednesday asked a state agency to produce in the next month an independent analysis of the costs associated with Question 1.
ADVERTISEMENT

TJX appoints new director, its fifth female member

TJX Cos. has elected a former executive at UBS Wealth Management USA as its newest director.

Marlborough frozen seafood company owner gets two years in prison

The owner of a former Marlborough-based seafood distributor has been sentenced to two years in federal prison for bank fraud.

The largest Central Mass. communities are bulking up their rainy day funds

Despite a long run of economic growth, economists are predicting when the next market correction or recession may hit.

Help Needed: Massachusetts has the largest construction worker shortage in the nation

With the Massachusetts unemployment rate at just 3.6 percent in July, construction firms simply can't find enough workers.
ADVERTISEMENT

The Point at Marlborough sells for $65M

The Point at Marlborough, a residential community off Brigham Street has sold for $65 million, a number that could set a high price mark for the year for Central Massachusetts.

SEC charges Marlborough’s Lemelson Capital with fraud

A Marlborough hedge fund adviser and his investment firm are being charged with profiting more than $1.3 million after driving down the price of a California pharmaceutical company.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA